The global sales of fluid transfer solutions are estimated to be worth USD 19,203.4 million in 2024 and are anticipated to reach a value of USD 30,398.0 million by 2034. Sales are projected to rise at a CAGR of 5.5% over the forecast period between 2024 and 2034. The revenue generated by fluid transfer solutions in 2023 was USD 18,202.3 million.
The market for fluid transfer solutions has expanded rapidly due to ongoing progress in research and development activities across various industries such as pharmaceutical, biotechnology, and medical devices. The demand for effective, reliable, and contamination-free fluid transfer and transfer systems has been heightened by the continuous introduction of new treatments, vaccines, and cell and gene therapy.
The pharmaceutical sector, in particular, is currently utilizing aseptic transfer techniques for products on both small and large scales in response to governmental regulations and laws that govern sterility for product integrity. The ability to move fluids or materials quickly, reliably, and easily is key to maintaining integrity, particularly in sterile product transfers, and is contributing to the increasing demand for fluid transfer solutions.
Global Fluid Transfer Solutions Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 18,202.3 million |
| Estimated Size, 2024 | USD 19,203.4 million |
| Projected Size, 2034 | USD 30,398.0 million |
| Value-based CAGR (2024 to 2034) | 5.5% |
The aseptic transfer of fluids and cellular materials is facilitated through specialized equipment and devices developed for the purpose to meet specific process or industry needs. These solutions are offered by different manufacturers, based on the product use and application. The fluid transfer solutions can vary and consist of single-use, disposable products or custom-developed systems.
Additionally, these results can differ in their composition, ranging from polyvinyl chloride (PVC), silicone, and stainless steel, which are widely used in the medical industry. Or else put, PVC is a familiar ingredient for different types of medical equipment such as tubes, blood packages, IV systems, liquid transfer systems, dialysis bags, and IV containers among many others.
In the biopharmaceutical industry, aseptic fluid transfer systems play an important role in single-use systems, peristaltic pump usage, and upstream and downstream operations, including fill-and-finish. The flexibility and compatibility associated with materials such as silicone and PVC further allow for the various systems to be used for several different applications.
The increasing move toward single-use systems (SUS) has been a key growth driver for the fluid transfer solutions market. They are quickly gaining traction due to the numerous benefits they offer. Single-use fluid transfer solutions improve facility design and minimize validation and operational costs, all while decreasing the risk of unintended cross-contamination.
Single-use systems expedite turnaround time, optimize flexibility, and provide better connectivity between fluid transfer processes. Combined with the benefits noted above, these advantages make single-use systems an important offering in the fluid transfer market. SUS is especially applicable to biopharmaceutical and healthcare applications.
As the demand for innovative portable fluid transfer solutions continues to increase, with projected demand being led by the growing pharmaceutical and biotechnology markets, the fluid transfer solutions market is poised for significant growth during the forecast period.
Additionally, the growing demand for aseptic, efficient, and customizable systems will enhance the growth in demand and be a relevant factor of the fluid transfer solutions area of operation for these industries.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The table below compares the compound annual growth rate (CAGR) for the global fluid transfer solutions market from 2023 to 2024 during the first half of the year. This overview highlights key changes and trends in revenue growth, offering valuable insights into market dynamics.
H1 covers January to June, while H2 spans July to December. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 6.2%, followed by a slightly lower growth rate of 5.9% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 6.2% (2023 to 2033) |
| H2 | 5.9% (2023 to 2033) |
| H1 | 5.5% (2024 to 2034) |
| H2 | 5.0% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 5.0% in the first half and remain relatively moderate at 5.5% in the second half. In the first half (H1) the market witnessed a decrease of 70 BPS while in the second half (H2), the market witnessed a decrease of 90 BPS.
Single-Use Systems Drive Growth in Fluid Transfer Solutions Market by Enhancing Flexibility and Reducing Contamination Risks
An essential aspect influencing the market for fluid transfer systems is the growing use of single use systems (SUS) in establishments with multi-batch production, including the manufacturing of seasonal vaccines. This is common, due to the necessity to reorganize the operation of all facilities on a per season/annual basis depending on the seasonal requirement for multiple batches. In these settings single-use systems offer significant advantages over comparative systems.
Fully eliminating the risk of cross-contamination is one of the key benefits, especially in environments where different biologic batches, or vaccines are hosted. With traditional stainless-steel systems, the risk of cross-contamination is addressed through extensive cleaning and sterilization between uses, whereas single use systems eliminate the need of cleaning along the fluid path, that are both time consuming and costly. This contributes to overall operational contamination, thereby improving production efficacy.
Single-use systems provide the opportunity to encourage workflow reconfiguration and design workflows with flexibility for a campaign-induced purpose. Simulations may be conducted on processes to identify the best flow diagrams for fluid, or volume of fluid, storage space of fluid, transfer of fluid, etc. to promote efficient future supply chain resources.
These simulations facilitate a facility's planning of short-term and long-term fluid storage and processing run-time, all while aiding not only operational efficiency into the future, but potentially uncovering processes for running efficient short-term campaigns with single-use systems.
In bustling environments where continued flexibility, speed of manufacturing, and fluctuations with seasonal demand are paramount in human FDA and EMA vaccine manufacturing, it is ultimately expected that there will be demand for more single-use fluid transfer systems. Single-use systems offer simplifications to otherwise complicated processes that reduce contamination, provide quicker manufacturing turnaround, and, assure the user of reliable single-use systems designed to work cooperatively.
These systems support the growth of the fluid transfer solutions market. Single-use systems will arguably be key components to future processes, as they assure fluid transfer systems exhibiting efficient multi-campaign manufacturing while keeping operations fluid, efficient, and contaminant-free.
Opportunity for Cost-Effective and Flexible Miniaturization in Drug Manufacturing
The increased trend toward miniaturization of drug development and manufacturing provides an important opportunity for single-use fluid transfer systems.
The pharmaceutical and biopharmaceutical industries are developing more precise therapies and modalities such as immunotherapies, biologics, and cell therapies, requiring more targeted therapies and solutions with benefits in the form of either smaller sizes or greater flexibility. Single-use systems often especially single-use bags offer defined benefits that would enable effective support for this trend.
A defined benefit in using single-use systems in support of miniaturization is cost. Traditional systems may incorporate large pieces of stainless steel or other reusable components that often require significant cleaning and sterilizing between batches. For larger batch sizes, this is a resource heavy process, but for smaller batch sizes, traditional systems become less realistic.
In order to follow industry trends and keep up with detailed special product batch sizes, single-use systems may easily provide the answer since the systems do not require any cleaning or sterilizing processes, resulting in labor savings as well as lower and quicker operational costs.
In addition to this reduced cost or cleaning and maintenance single-use systems also provide a high level of flexibility or scalability in their capability. Single-use systems can fit into the limited available space that a smaller batch infrastructure systems may otherwise come in the context of scale in size, requiring only limited adjustments.
Consequently, this has major advantages as during a production run, special products are often produced at low batch sizes and require too frequently change overs between products and batch size that single-use systems allow resolutions enabling flexibility efficiently during transitions, which is important more generally as many further products and/or formulations become more specialized to markets.
Taken together, these features of minimizing the practical and effective option to help companies effectively control more specialized products and batch sizes align with the observed industry trend associated with miniaturization and create a compelling growth opportunity for single-use supervised fluid solutions in the market.
Advanced Polymer Materials Enhance Performance and Safety in Fluid Transfer Systems
A trend in the fluid transfer solutions market includes advancements in the use of polymer materials in these systems. The reason for this trend is the need for higher performance, increased reliability, and higher safety in fluid handling operations, such as in pharma, biology, biotech, and other industries. The advancement of future polymer materials, specifically high-end silicone and thermoplastic polymers, helps address many of the limitations of single-use systems.
Initially, they have superior chemical resistance. This is critical for being able to handle a wide variety of fluids, which can be degradation chemicals and also biologics or other sensitive fluids. This chemical resistance eliminates the ability for a chemical fluid to degrade the polymer polymeric materials and is critical for retaining its integrity to handle the targeted fluid.
In addition to the chemical resistance, there exist enhanced mechanical properties for these advanced polymers. Specifically, high-end silicones and thermoplastics can support higher strength and flexibility when compared to a traditional TPE in terms of handling pressures, typically preventing the occurrence of leaks and or failures when moving targeted fluids in a device for application.
Therefore, addressing the targeted issues in handling sensitive and value-based fluids with these advanced materials will address the demand towards the future for advanced, reliable, and safe fluid transfer products in manufacturing systems.
Traditional Liquid Control Systems Limit Scalability and Efficiency in Biopharmaceutical Manufacturing
In the fluid transfer solutions industry - specifically within biopharmaceutical manufacturing, a primary limiting factor is the usage of old liquid control systems, such as stainless steel piping. This type of system is common in industrial applications, and it is accompanied by challenges at biopharmaceutical manufacturing, specifically with regard to regulatory and safety expectations.
Biopharmaceuticals manufacturing must be done under strict sterile/aseptic conditions, or bioburden levels must not violate current good manufacturing practices (cGMP).
The patterned regiment must accompany extensive cleaning, which can introduce a risk into the process flows, such as (CIP) clean-in-place or (SIP) sterilized-in-place practices, to return the process systems to the desired sterile/aseptic conditions, before any process liquid is introduced into any other vessel or process pipeline.
While this high hurdle is necessary for sterile/aseptic workflows, it is notoriously inefficient in terms of scalability and cost. Cleaning and sterilization will consume resources, including labor, time, and footprint at the plant itself, interferences that will add complexity to the overall biopharmaceutical manufacturing timing and flexibility of operations.
For a company willing to scale its operations or run multiple campaigns for production, there will only be high risk of push-back by local regulators as dated systems will require extensive validation and preparation before the new or updated systems are deemed acceptable.
Additionally, these systems are less adaptable to rapid changes in production demands, making it difficult for facilities to quickly pivot between different manufacturing processes.
This lack of scalability and cost efficiency inherent in traditional liquid control systems can restrain the growth of the fluid transfer solutions market, as manufacturers look for more flexible and resource-efficient alternatives to address these limitations. Consequently, the time and resource intensity of these processes can hinder faster market expansion in highly regulated industries like biopharmaceuticals.
Principal Consultant
The global fluid transfer solutions industry recorded a CAGR of 4.7% during the historical period between 2019 and 2023. The growth of the fluid transfer solutions industry was positive as it reached a value of USD 30,398.0 million in 2034 from USD 19,203.4 million in 2024.
Before the emergence of the COVID-19 pandemic, the fluid transfer solutions market was undergoing sustainable growth, primarily due to the demand witnessed in the pharmaceutical, biotechnology, and medical device industries.
Growing demand for aseptic processes, single-use systems, and combating the risk of contamination with safer, more efficient fluid transfer systems encouraged an increase in market growth; however, growth levels were sustained with advances in treatment development and bioprocessing.
Once the pandemic began, the market underwent a sudden spike in global demand for vaccines, diagnostics, and other necessary medical products.
The battle against COVID-19 propelled the adoption of advanced fluid transfer systems and single-use technologies, as manufacturers and suppliers were pressured to quickly produce more fluids at higher throughputs; all while maintaining the safety and functionality of the picking and mixing fluids in their own aseptic environments. Thus, the fluid transfer market experienced a historical unsustainable spike in CAGR for those periods.
Further, the greater push in the healthcare sector to implement greater efficiencies and to achieve greater flexibility will continue to create favorable conditions benefitting growth in demand for advanced fluid solutions market. In conclusion, the growth in the fluid transfer market and its applications will continue to build positive growth momentum underpinned by green field innovations and continued opportunity to leverage the implementation of single-use systems.
Tier 1 companies are the major companies as they hold a 47.4% share worldwide. These companies have large product portfolio and a high production capacity. Companies with a wide range of products, a global presence, and robust research and development capabilities are key players in pharmaceuticals, biotechnology, and research sectors.
Their broad applications and innovative solutions contribute to their leadership in the market. Prominent companies within tier 1 include Thermo Fisher Scientific, Avantor Inc, Pall Corporation and Sartorius AG
Tier 2 companies are relatively smaller as compared with tier 1 players. The tier 2 companies hold a share of 24.2% worldwide. Firms in this tier providing a diverse array of fluid transfer and laboratory products, with a significant emphasis on biopharmaceuticals, demonstrate strong market positions.
Their commitment to innovation and comprehensive product lines supports their prominent status. Key Companies under this category include DuPont, Saint-Gobain Performance Plastics, Watson Marlow Fluid Technology Group and Beckman Coulter Inc.
Compared to Tiers 1 and 2, Tier 3 companies offer fluid transfer solutions, but with smaller revenue spouts and less influence. These companies mostly operate in one or two countries and have limited customer base. Tier 3 companies, although, smaller but are essential for the market. The companies such as Charter Medical, Cellon, Central Research Laboratories and other falls under this category.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis for the fluid transfer solutions market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided. The USA is anticipated to remain at the forefront in North America, with higher market share through 2034. In Asia Pacific, India is projected to witness a CAGR of 8.4% by 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| USA | 2.0% |
| Germany | 2.1% |
| UK | 2.5% |
| China | 8.0% |
| India | 8.4% |
The USA dominates the global market and is poised to exhibit a CAGR of 2.0% between 2024 and 2034. Currently, it holds the highest share in the North America market, and the trend is expected to continue during the forecast period.
As recently exemplified in a recent report from the National Institutes of Health (NIH), the NIH spends nearly USD 41 billion per year on medical research, with over 80% of this funding going to research institutions and medical schools, while the rest of the funding supports independent projects across the USA This significant amount of funding shows the nation's focus on advancing both medical science and clinical research.
This increased amount of funding has increased the need for aseptic transfer of materials and drugs for both clinical trials and research studies since those involved with clinical trials and performing research studies need to keep their materials meeting sterile conditions to maintain success in their research processes.
The variability factor for this growing need will provide support and substantial growth to the fluid transfer solutions market in the USA during the forecast period as organizations begin to seek solutions to ensure safety during the research process and overall, their overall research processes.
Germany dominates the Western Europe market and is poised to exhibit a CAGR of 2.1% between 2024 and 2034. Germany’s considerable investment in medical research and focus on precision healthcare continues to have a strong impact on the market for solutions for transferring fluids safely.
With increased investment from both the government and the private sector, the nation is advancing clinical research and medical technology. This increased investment will coincide with an increase in focus on fluid transfer and maintaining sterile conditions to ensure quality and efficacy in medical processes.
As the country continues to emphasize advanced research and quality in healthcare, aseptic fluid transfer solutions will be in high demand throughout the forecast period. This will lead to market growth in the sector with healthcare and medical research organizations looking for advanced systems to suit their stringent requirements and more significant research agenda throughout the forecast period.
China dominates the East Asia market and is poised to exhibit a CAGR of 8.0% between 2024 and 2034. On October 23, 2023, the National Medical Products Administration (NMPA) issued a new regulation updating its oversight of marketing authorization holders’ (MAHs) manufacturing responsibilities when manufacturing drugs on behalf of MAHs, with the assistance of contract manufacturing organizations (CMOs).
This regulation requires that each MAH ensure that their qualified person (QP) and person responsible for manufacture and quality (PRMQ) have a minimum of five years’ experience in drug manufacture and quality. The PRMQ experience must include three years with sterile drugs.
This regulatory update addresses complexities in the MAH mechanism and practice when the MAH outsources drug manufacture. It implies an expectation for higher levels of drug production and greater assurance of quality of drug products.
This will create continued demand for more advanced aseptic fluid transfer solutions in China, as the complexity of drug manufacturing induced by quality and sterility considerations increases. This revised regulation is anticipated to support the anticipated market growth of fluid transfer solutions, of which will be driven in-part by continued R&D and a focus on compliance with greater standards of manufacturing quality.
The section contains information about the leading segments in the industry. Based on application, the standard/single use fluid transfer systems segment is expected to account 65.2% of the global share in 2024.
| Application | Standard/Single Use Fluid Transfer Systems |
|---|---|
| Value Share (2024) | 65.2% |
Standard/single use fluid transfer systems accounted for 26.3% of the application segment in 2023. Standard/single-use systems for fluid transfer, have transformed the pharmaceutical and biopharmaceutical field by offering unprecedented convenience and efficiency. These systems eliminate the resource-intensive cleaning and sterilization protocols, mitigating risk of cross-contamination along with delivering enhanced sterility.
They are able to be deployed rapidly and fitted to varying uses, which is paramount for handling complicated processes and product quality. As product volumes and types increase, the versatility and affordability of single-use systems are advantageous as they lead in the advancement of the industry.
| End User | Biopharmaceutical Industry |
|---|---|
| Value Share (2024) | 50.2% |
Biopharmaceutical industry for 50.2% of the end user segment in 2023. The biopharmaceutical industry has robust needs for high-precision fluid transfer solutions in the development and production of biologics, cell and gene therapies, and other sensitive therapeutics. The complex requirements for sterility and process control in the industry continue to drive demand for innovative single-use systems that are designed to avoid contamination in operations.
Moreover, these systems are essential for the protection and efficacy of biologics when handled according to strict ADA standards. The growing complexity of biopharmaceutical processes, as well as the need for scalable and adaptable solutions, are instrumental to fluid transfer systems remaining a significant and major player in the biopharmaceutical industry.
Key players in the market are focusing on several crucial areas. They are innovating single-use systems to enhance efficiency and minimize contamination risks, while ensuring high standards of sterility and safety to meet strict regulatory requirements. Customization and scalability are also priorities, providing solutions that cater to various batch sizes and specific industry needs.
Recent Industry Developments in Fluid Transfer Solutions Market
In terms of application, the industry is divided into standard/ single use fluid transfer systems and customized/ multiple use fluid transfer systems.
In terms of end user, the industry is segregated into Medical industry, Biopharmaceutical Industry and Cell and Gene therapy industry
Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
The global fluid transfer solutions industry is projected to witness CAGR of 5.5% between 2024 and 2034.
The global fluid transfer solutions industry stood at USD 18,202.3 million in 2023.
The global fluid transfer solutions industry is anticipated to reach USD 30,398.0 million by 2034 end.
China is expected to show a CAGR of 8.0% in the assessment period.
The key players operating in the global fluid transfer solutions industry include Thermo Fisher Scientific, Charter Medical, Watson Marlow Fluid Technology Group, Avantor Inc, DuPont, Saint-Gobain Performance Plastics, Cellon, Pall Corporation, Sartorius AG, Getinge AB, Central Research Laboratories, Beckman Coulter Inc and others.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Applications 6.2. End User 7. Global Market Analysis and Forecast, By Applications 7.1. Standard/ Single Use fluid transfer systems 7.2. Customized/ Multiple use fluid transfer systems 8. Global Market Analysis and Forecast, By End User 8.1. Medical industry 8.2. Biopharmaceutical industry 8.3. Cell and Gene therapy industry 9. Global Market Analysis and Forecast, By Region 9.1. North America 9.2. Latin America 9.3. Europe 9.4. South Asia 9.5. East Asia 9.6. Oceania 9.7. Middle East and Africa 10. North America Sales Analysis and Forecast, by Key Segments and Countries 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries 12. Europe Sales Analysis and Forecast, by Key Segments and Countries 13. South Asia Sales Analysis and Forecast, by Key Segments and Countries 14. East Asia Sales Analysis and Forecast, by Key Segments and Countries 15. Oceania Sales Analysis and Forecast, by Key Segments and Countries 16. Middle East and Africa Sales Analysis and Forecast, by Key Segments and Countries 17. Sales Forecast by Applications and End User for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Thermo Fisher Scientific 19.2. Charter Medical 19.3. Watson Marlow Fluid Technology Group 19.4. Avantor Inc 19.5. DuPont 19.6. Saint-Gobain Performance Plastics 19.7. Cellon 19.8. Pall Corporation 19.9. Sartorius AG 19.10. Getinge AB 19.11. Central Research Laboratories 19.12. Beckman Coulter Inc
Explore Healthcare Insights
View Reports
Fluid Transfer Solutions Market
